Acquired perioral cutaneous Langerhans cell histiocytosis.


How to Cite

Khedim N., Hali F., El Fatoiki F.Z., Chiheb S. 2022. Acquired perioral cutaneous Langerhans cell histiocytosis. Eur. J. Pediat. Dermatol. 32 (1):62-4. 10.26326/2281-9649.32.1.2327.


Khedim N. Hali F. El Fatoiki F.Z. Chiheb S.
pp. 62-4


LCH is an inflammatory neoplasm consisting of cells derived from medullary precursors, which usually have mutations of the MAPK signaling pathway (1). The spectrum of LCH is extremely large ranging from a single lesion affecting a single organ, generally bone or skin, to generalized multisystem lesions. The prognosis of the disease is also extremely variable, ranging from spontaneous resolution in a few months in the forms affecting only one organ to death in a few weeks in the multisystem forms with organ dysfunction.


Histiocytosis, Langerhans cells, skin, mouth